Marksans Pharma Faces Significant Volatility Amid Broader Market Declines

Marksans Pharma, a midcap player in the Pharmaceuticals & Drugs sector, has experienced significant volatility today, with a decline of 5.65% as of April 7, 2025. The stock opened sharply lower, down 18.82%, and reached an intraday low of Rs 168.05. Over the past two days, Marksans Pharma has seen a cumulative drop of 16.2%, underperforming its sector, which has fallen by 3.11%. In terms of moving averages, the stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. The stock's intraday volatility was recorded at 9.79%, reflecting heightened market activity. Comparatively, Marksans Pharma's performance over various time frames shows a stark contrast to the broader market. Over the past week, the stock has declined by 12.66%, while the Sensex has decreased by 5.62%. Year-to-date, Marksans Pharma has lost 34.55%, compared to the Sensex's decline of 6.49%. However, the stock has shown resilience over longer periods, with a remarkable 232.88% increase over the past three years and a staggering 991.16% rise over the last five years.